Unichem Laboratories

Digital Transformation Summit India Announces The Top 100 Digital Leaders In India

Retrieved on: 
Monday, November 20, 2023

MUMBAI, INDIA, Nov 20, 2023 - (ACN Newswire) - The Digital Transformation Summit, India, a premier event at the forefront of technological innovation, is thrilled to unveil DT 100, a prestigious initiative that recognises the remarkable achievements of technology leaders in India.

Key Points: 
  • MUMBAI, INDIA, Nov 20, 2023 - (ACN Newswire) - The Digital Transformation Summit, India, a premier event at the forefront of technological innovation, is thrilled to unveil DT 100, a prestigious initiative that recognises the remarkable achievements of technology leaders in India.
  • The DT 100 felicitation will take place at the Digital Transformation Summit in Mumbai on the 6th of December.
  • As we eagerly anticipate the Digital Transformation Summit, we extend our heartfelt congratulations to the 100 leaders who are paving the way for a digitally empowered future.
  • For more information about the Digital Transformation Summit India and the DT 100, please visit https://digitransformationsummit.com/india/

Global Buprenorphine Market to Surpass US$ 10,898.8 Million by 2027, Says Coherent Market Insights (CMI)

Retrieved on: 
Thursday, October 15, 2020

According to Coherent Market Insights, the global buprenorphine market is estimated to be valued at US$ 3,681.9 million in 2020 and is expected to exhibit a CAGR of 14.5% during the forecast period (2020-2027).

Key Points: 
  • According to Coherent Market Insights, the global buprenorphine market is estimated to be valued at US$ 3,681.9 million in 2020 and is expected to exhibit a CAGR of 14.5% during the forecast period (2020-2027).
  • Market players are actively launching generic versions of buprenorphine for cost effective and quality treatment.
  • Moreover, the players are committed to offer new and improved products to address the critical unmet needs of patients.
  • Key players operating in the global buprenorphine market are Siegfried, Sanofi, Johnson Matthey, Mallinckrodt, Noramco, Inc., Unichem Laboratories, Arevipharma GmbH, Resonance-labs, Sun Pharmaceutical Industries Ltd., Rusan Pharma, Micro Orgo Chem, and Faran Shimi Pharmaceutical Co.

Unichem Pharma Announces Executive Leadership Change

Retrieved on: 
Thursday, June 21, 2018

Mr. Delaney has worked with outstanding organizations such as Eli Lilly and Company, Johnson and Johnson, HEB Grocery Company, Teva Pharmaceuticals, URL Pharma, Cadista Pharmaceuticals, and Edenbridge Pharmaceuticals.

Key Points: 
  • Mr. Delaney has worked with outstanding organizations such as Eli Lilly and Company, Johnson and Johnson, HEB Grocery Company, Teva Pharmaceuticals, URL Pharma, Cadista Pharmaceuticals, and Edenbridge Pharmaceuticals.
  • Mr. Delaney commented, "I am honored to accept the role of President and Chief Executive Officer North America for Unichem at this exciting time for the company.
  • Unichem Pharmaceuticals (USA), Inc.is a specialty pharmaceutical company engaged in the development, marketing and distribution of generic pharmaceutical products in the United States.
  • Unichem Pharmaceuticals (USA), Inc. is a wholly owned subsidiary of Unichem Laboratories Limited .The majority of Unichem products are vertically integrated with in-house active pharmaceutical ingredients.